Active ingredient : Olaparib Olaparib
Couldn't load pickup availability
Free shipping and returns available on all orders!
We ship all US domestic orders within 5-10 business days
Olpaza, containing olaparib, is a targeted therapy used primarily in the treatment of certain types of cancer, including breast, ovarian, pancreatic, and prostate cancers that are associated with homologous recombination deficiency (HRD). This medication works by inhibiting the enzyme poly (ADP-ribose) polymerase (PARP), which plays a crucial role in repairing damaged DNA.
Olpaza is prescribed for patients with specific genetic mutations, particularly those with BRCA1 or BRCA2 mutations. It may be used as a monotherapy or in combination with other treatments to enhance the effectiveness of cancer therapy.
Olpaza targets cancer cells with defective DNA repair mechanisms, leading to the accumulation of DNA damage and ultimately resulting in cell death. This mechanism is particularly effective in tumors that are already vulnerable due to genetic mutations.
Olpaza is typically recommended for patients with advanced cancer who have undergone previous treatments and have specific genetic markers. It is essential to consult with a healthcare professional to determine if Olpaza is appropriate for individual cases.
Common side effects of Olpaza may include nausea, fatigue, anemia, and gastrointestinal disturbances. Serious side effects can occur, so patients should report any unusual symptoms to their healthcare provider immediately.
Olpaza is usually taken orally in the form of tablets. It is essential to follow the prescribed dosage and schedule provided by a healthcare professional to ensure optimal efficacy and safety.
Before starting Olpaza, inform your doctor about your complete medical history, especially any previous cancer treatments, current medications, and any existing health conditions. This information is crucial for assessing potential interactions and side effects.
For detailed information about Olpaza, including clinical studies, usage guidelines, and patient support resources, consult your healthcare provider or visit reputable medical websites and cancer support organizations.